These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 4832604)
1. Evidence for a post-secretory reabsorptive site for uric acid in man. Diamond HS; Sharon E Adv Exp Med Biol; 1974; 41():745-9. PubMed ID: 4832604 [No Abstract] [Full Text] [Related]
2. Evidence for a postsecretory reabsorptive site for uric acid in man. Diamond HS; Paolino JS J Clin Invest; 1973 Jun; 52(6):1491-9. PubMed ID: 4703233 [TBL] [Abstract][Full Text] [Related]
3. The pharmacology of the hypouricemic effect of benzbromarone. Fox IH; Sinclair DS Adv Exp Med Biol; 1977; 76B():328-33. PubMed ID: 855759 [No Abstract] [Full Text] [Related]
4. Evidence for two secretory mechanisms for organic acid transport in man. Diamond HS; Meisel AD Adv Exp Med Biol; 1977; 76B():56-62. PubMed ID: 855763 [No Abstract] [Full Text] [Related]
5. Postsecretory reabsorption of urate in man. Diamond HS; Meisel AD Arthritis Rheum; 1975; 18(6 Suppl):805-9. PubMed ID: 1201124 [TBL] [Abstract][Full Text] [Related]
6. Classification of uricosuric states based upon response to pharmacologic inhibitors of urate transport. Diamond HS; Meisel AD Adv Exp Med Biol; 1977; 76B():63-71. PubMed ID: 855764 [No Abstract] [Full Text] [Related]
7. [Effect of transtubular transport inhibitors in the renal excretion of uric acid in the rat]. Boudry JF Pflugers Arch; 1971; 328(4):279-91. PubMed ID: 5107270 [No Abstract] [Full Text] [Related]
8. Pharmacologic effects of nicotinic acid on human purine metabolism. Gershon SL; Fox IH J Lab Clin Med; 1974 Aug; 84(2):179-86. PubMed ID: 4367231 [No Abstract] [Full Text] [Related]
9. Studies of interactions among drugs in man at the renal level: probenecid and sulfinpyrazone. Perel JM; Dayton PG; Snell MM; Yü TF; Gutman AB Clin Pharmacol Ther; 1969; 10(6):834-40. PubMed ID: 5349624 [No Abstract] [Full Text] [Related]
10. Comments on the use of pyrazinamide. Steele TH Arthritis Rheum; 1975; 18(6 Suppl):817-21. PubMed ID: 1201126 [No Abstract] [Full Text] [Related]
11. Bidirectional renal urate transport in the chimpanzee. Effects of drugs on secretory and reabsorptive fluxes. Fanelli GM; Weiner IM Prog Biochem Pharmacol; 1974; 9():163-73. PubMed ID: 4438378 [No Abstract] [Full Text] [Related]
12. Uric acid transport in renal failure. A review. Danovitch GM Nephron; 1972; 9(5):291-9. PubMed ID: 4575097 [No Abstract] [Full Text] [Related]
13. Pharmacologic approach to the maintenance of urate homeostasis. Kelley WN Nephron; 1975; 14(1):99-115. PubMed ID: 1091870 [TBL] [Abstract][Full Text] [Related]
14. Hypouricemia due to renal tubular defect. A study with the probenecid-pyrazinamide test. Smetana SS; Bar-Khayim Y Arch Intern Med; 1985 Jul; 145(7):1200-3. PubMed ID: 4015266 [TBL] [Abstract][Full Text] [Related]
16. The tubular site of urate transport in the rabbit kidney, and the effect of probenecid on urate secretion. Moller JV Acta Pharmacol Toxicol (Copenh); 1965; 23(4):329-36. PubMed ID: 5899691 [No Abstract] [Full Text] [Related]
17. Pharmacologic evaluation of the renal handling of uric acid and oxypurines. Hiroshige K; Takasugi M; Yuu K; Kuroiwa A Nihon Jinzo Gakkai Shi; 1994 Nov; 36(11):1268-75. PubMed ID: 7853759 [TBL] [Abstract][Full Text] [Related]
18. The effect of the interaction of pyrazinamide and probenecid on urinary uric acid excretion in man. Yü TF; Perel J; Berger L; Roboz J; Israili ZH; Dayton PG Am J Med; 1977 Nov; 63(5):723-8. PubMed ID: 930947 [TBL] [Abstract][Full Text] [Related]
19. A case of uric acid renal stone with hypouricemia caused by tubular reabsorptive defect of uric acid. Kawabe K; Murayama T; Akaoka I J Urol; 1976 Dec; 116(6):690-2. PubMed ID: 1003631 [TBL] [Abstract][Full Text] [Related]
20. Urate secretion in man: the pyrazinamide suppression test. Steele TH Ann Intern Med; 1973 Nov; 79(5):734-7. PubMed ID: 4201636 [No Abstract] [Full Text] [Related] [Next] [New Search]